A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Novo Nordisk board members step down after major shareholder dispute
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
How Lego MRI scanner sets are reducing anxiety in children
People depart a Lego store in Manhattan on August 29, 2024 in New York City. Spencer Platt |…
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case
In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
Trump, Pfizer to announce agreement to lower Medicaid drug prices
U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in…
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Democrats dig in on health care as threat of government shutdown looms
U.S. Senate Minority Leader Chuck Schumer (D-NY) speaks to reporters as Senate Democratic leaders hold a press conference…
Wegovy-maker Novo Nordisk to cut around 9,000 jobs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
MAHA loves dietary supplements. But that hasn’t led to gains in Washington — yet.
An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…